{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:55:42Z","timestamp":1791147342139,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T00:00:00Z","timestamp":1358467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00417-013-2257-z","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T23:03:04Z","timestamp":1358377384000},"page":"1529-1540","source":"Crossref","is-referenced-by-count":19,"title":["EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification"],"prefix":"10.1007","volume":"251","author":[{"given":"C.","family":"Wertheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Liegl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kernt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Docheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kampik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Eibl-Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,18]]},"reference":[{"key":"2257_CR1","unstructured":"World Health Organisation Prevention of Blindness and Visual Impairment. Priority eye disease: Cataract. Available: http:\/\/www.who.int\/blindness\/causes\/priority\/en\/index1.html . Accessed 18 January 2012"},{"key":"2257_CR2","doi-asserted-by":"crossref","first-page":"xiv","DOI":"10.1007\/978-3-642-02602-7","volume-title":"Minimally invasive ophthalmic surgery","author":"IH Fine","year":"2010","unstructured":"Fine IH, Mojon DS (2010) Minimally invasive ophthalmic surgery. Springer, Berlin, p xiv, 241 pp"},{"issue":"4","key":"2257_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archopht.125.4.555","volume":"125","author":"ME Wilson","year":"2007","unstructured":"Wilson ME, Trivedi RH (2007) The ongoing battle against posterior capsular opacification. Arch Ophthalmol 125(4):555\u2013556","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"2257_CR4","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1167\/iovs.02-0634","volume":"44","author":"WR Meacock","year":"2003","unstructured":"Meacock WR, Spalton DJ, Boyce J, Marshall J (2003) The effect of posterior capsule opacification on visual function. Invest Ophthalmol Vis Sci 44(11):4665\u20134669","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2257_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/exer.2001.1153","volume":"74","author":"IM Wormstone","year":"2002","unstructured":"Wormstone IM (2002) Posterior capsule opacification: a cell biological perspective. Exp Eye Res 74(3):337\u2013347","journal-title":"Exp Eye Res"},{"issue":"2","key":"2257_CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.exer.2008.10.016","volume":"88","author":"IM Wormstone","year":"2009","unstructured":"Wormstone IM, Wang L, Liu CSC (2009) Posterior capsule opacification. Exp Eye Res 88(2):257\u2013269","journal-title":"Exp Eye Res"},{"issue":"5","key":"2257_CR7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0886-3350(13)80004-1","volume":"19","author":"JA Davison","year":"1993","unstructured":"Davison JA (1993) Capsule contraction syndrome. J Cataract Refract Surg 19(5):582\u2013589","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"2257_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1444-0938.2011.00640.x","volume":"95","author":"H Lam","year":"2012","unstructured":"Lam H, Visvaraja S (2012) Spontaneous dislocation of intraocular lens as a late complication of uncomplicated cataract surgery: a case series. Clin Exp Optom 95(1):99\u2013102","journal-title":"Clin Exp Optom"},{"issue":"4","key":"2257_CR9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0161-6420(02)01980-2","volume":"110","author":"GU Auffarth","year":"2003","unstructured":"Auffarth GU, Golescu A, Becker KA, V\u00f6lcker HE (2003) Quantification of posterior capsule opacification with round and sharp edge intraocular lenses. Ophthalmology 110(4):772\u2013780","journal-title":"Ophthalmology"},{"issue":"6","key":"2257_CR10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ajo.2007.02.017","volume":"143","author":"W Buehl","year":"2007","unstructured":"Buehl W, Menapace R, Findl O, Neumayer T, Bolz M, Prinz A (2007) Long-term effect of optic edge design in a silicone intraocular lens on posterior capsule opacification. Am J Ophthalmol 143(6):913\u2013919","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"2257_CR11","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jcrs.2004.01.042","volume":"30","author":"S Sacu","year":"2004","unstructured":"Sacu S, Menapace R, Buehl W, Rainer G, Findl O (2004) Effect of intraocular lens optic edge design and material on fibrotic capsule opacification and capsulorhexis contraction. J Cataract Refract Surg 30(9):1875\u20131882","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"2257_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0161-6420(00)00589-3","volume":"108","author":"DJ Apple","year":"2001","unstructured":"Apple DJ, Peng Q, Visessook N, Werner L, Pandey SK, Escobar-Gomez M, Ram J, Auffarth GU (2001) Eradication of posterior capsule opacification. Ophthalmology 108(3):505\u2013518","journal-title":"Ophthalmology"},{"issue":"3","key":"2257_CR13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcrs.2008.11.044","volume":"35","author":"L Vock","year":"2009","unstructured":"Vock L, Menapace R, Stifter E, Georgopoulos M, Sacu S, Buehl W (2009) Posterior capsule opacification and neodymium:YAG laser capsulotomy rates with a round-edged silicone and a sharp-edged hydrophobic acrylic intraocular lens 10\u00a0years after surgery. J Cataract Refract Surg 35(3):459\u2013465","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"2257_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0886-3350(97)80161-7","volume":"23","author":"RR Holweger","year":"1997","unstructured":"Holweger RR, Marefat B (1997) Intraocular pressure change after Neodymium:YAG capsulotomy. J Cataract Refract Surg 23(1):115\u2013121","journal-title":"J Cataract Refract Surg"},{"issue":"10","key":"2257_CR15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0161-6420(92)31775-0","volume":"99","author":"JC Javitt","year":"1992","unstructured":"Javitt JC, Tielsch JM, Canner JK, Kolb MM, Sommer A, Steinberg EP (1992) National outcomes of cataract extraction. Increased risk of retinal complications associated with Nd:YAG laser capsulotomy. The Cataract Patient Outcomes Research Team. Ophthalmology 99(10):1487\u20131497, discussion 1497\u20131498","journal-title":"Ophthalmology"},{"issue":"5","key":"2257_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0886-3350(13)80233-7","volume":"20","author":"TJ Newland","year":"1994","unstructured":"Newland TJ, Auffarth GU, Wesendahl TA, Apple DJ (1994) Neodymium:YAG laser damage on silicone intraocular lenses. A comparison of lesions on explanted lenses and experimentally produced lesions. J Cataract Refract Surg 20(5):527\u2013533","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"2257_CR17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1444-0938.2010.00532.x","volume":"93","author":"AL Sheppard","year":"2010","unstructured":"Sheppard AL, Bashir A, Wolffsohn JS, Davies LN (2010) Accommodating intraocular lenses: a review of design concepts, usage and assessment methods. Clin Exp Optom 93(6):441\u2013452","journal-title":"Clin Exp Optom"},{"issue":"10","key":"2257_CR18","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0886-3350(97)80028-4","volume":"23","author":"O Nishi","year":"1997","unstructured":"Nishi O, Nakai Y, Mizumoto Y, Yamada Y (1997) Capsule opacification after refilling the capsule with an inflatable endocapsular balloon. J Cataract Refract Surg 23(10):1548\u20131555","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"2257_CR19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcrs.2007.09.042","volume":"34","author":"O Nishi","year":"2008","unstructured":"Nishi O, Nishi K, Nishi Y, Chang S (2008) Capsular bag refilling using a new accommodating intraocular lens. J Cataract Refract Surg 34(2):302\u2013309","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"2257_CR20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0886-3350(99)80020-0","volume":"25","author":"O Nishi","year":"1999","unstructured":"Nishi O (1999) Posterior capsule opacification. Part 1: experimental investigations. J Cataract Refract Surg 25(1):106\u2013117","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"2257_CR21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archophthalmol.2009.3","volume":"127","author":"N Awasthi","year":"2009","unstructured":"Awasthi N, Guo S, Wagner BJ (2009) Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol 127(4):555\u2013562","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"2257_CR22","first-page":"622","volume":"44","author":"L Zhang","year":"2008","unstructured":"Zhang L, Wang N, Zhang W, Chang Z (2008) Suppression of cell proliferation by inhibitors to redox signaling in human lens epithelial cells. Zhonghua Yan Ke Za Zhi 44(7):622\u2013628","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"3","key":"2257_CR23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcrs.2005.08.063","volume":"32","author":"J Kampmeier","year":"2006","unstructured":"Kampmeier J, Baldysiak-Figiel A, de Jong-Hesse Y, Lang GK, Lang GE (2006) Effect of growth factors on proliferation and expression of growth factor receptors in a human lens epithelial cell line. J Cataract Refract Surg 32(3):510\u2013514","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"2257_CR24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000267748","volume":"27","author":"K Majima","year":"1995","unstructured":"Majima K (1995) Human lens epithelial cells proliferate in response to exogenous EGF and have EGF and EGF receptor. Ophthalmic Res 27(6):356\u2013365","journal-title":"Ophthalmic Res"},{"issue":"2","key":"2257_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jop.2006.22.93","volume":"22","author":"Q Jiang","year":"2006","unstructured":"Jiang Q, Zhou C, Bi Z, Wan Y (2006) EGF-induced cell migration is mediated by ERK and PI3K\/AKT pathways in cultured human lens epithelial cells. J Ocul Pharmacol Ther 22(2):93\u2013102","journal-title":"J Ocul Pharmacol Ther"},{"key":"2257_CR26","first-page":"2349","volume":"17","author":"W Huang","year":"2011","unstructured":"Huang W, Fan X, Tang X (2011) SiRNA targeting EGFR effectively prevents posterior capsular opacification after cataract surgery. Mol Vis 17:2349\u20132355","journal-title":"Mol Vis"},{"issue":"1","key":"2257_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrd1612","volume":"4","author":"J Dowell","year":"2005","unstructured":"Dowell J, Minna JD, Kirkpatrick P (2005) erlotinib hydrochloride. Nat Rev Drug Discov 4(1):13\u201314","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"2257_CR28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1634\/theoncologist.2010-0257","volume":"15","author":"MH Cohen","year":"2010","unstructured":"Cohen MH, Johnson JR, Chattopadhyay S, Tang S, Justice R, Sridara R, Pazdur R (2010) Approval summary: erlotinib maintenance therapy of advanced\/metastatic non-small cell lung cancer (NSCLC). Oncologist 15(12):1344\u20131351","journal-title":"Oncologist"},{"key":"2257_CR29","unstructured":"FDA (2004) FDA label information for erlotinib [online]. Available: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021743s14s16lbl.pdf . Accessed 11 August 2011"},{"key":"2257_CR30","unstructured":"European medicines agency (EMA) Authorisation details of Traceva (erlotinib). Available: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000618\/human_med_001077.jsp&mid=WC0b01ac058001d124&jsenabled=true . Accessed 25 January 2012"},{"issue":"4\u20135","key":"2257_CR31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1159\/000320096","volume":"28","author":"J M\u00f6ssner","year":"2010","unstructured":"M\u00f6ssner J (2010) What\u2019s new in therapy of pancreatic cancer. Dig Dis 28(4\u20135):679\u2013683","journal-title":"Dig Dis"},{"key":"2257_CR32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-540-71279-4_15","volume":"177","author":"S Heeger","year":"2008","unstructured":"Heeger S (2008) Targeted therapy of the epidermal growth factor receptor in the treatment of pancreatic cancer. Recent Results Cancer Res 177:131\u2013136","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"2257_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/10482880-000000000-00000","volume":"28","author":"KA Lyseng-Williamson","year":"2010","unstructured":"Lyseng-Williamson KA (2010) erlotinib. Pharmacoeconomics 28(1):75\u201392","journal-title":"Pharmacoeconomics"},{"issue":"18","key":"2257_CR34","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1158\/1078-0432.CCR-05-0790","volume":"11","author":"J Johnson","year":"2005","unstructured":"Johnson J, Cohen M, Sridhara R, Chen Y, Williams GM, Duan J, Gobburu J, Booth B, Benson K, Leighton J, Hsieh LS, Chidambaram N, Zimmerman P, Pazdur R (2005) Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Clin Cancer Res 11(18):6414\u20136421","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2257_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00280-009-1133-3","volume":"66","author":"M Ranson","year":"2010","unstructured":"Ranson M, Shaw H, Wolf J, Hamilton M, McCarthy S, Dean E, Reid A, Judson I (2010) A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin. Cancer Chemother Pharmacol 66(1):53\u201358","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"2257_CR36","first-page":"3094","volume":"35","author":"UP Andley","year":"1994","unstructured":"Andley UP, Rhim JS, Chylack LT, Fleming TP (1994) Propagation and immortalization of human lens epithelial cells in culture. Invest Ophthalmol Vis Sci 35(7):3094\u20133102","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2257_CR37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1600-0420.2000.078002130.x","volume":"78","author":"J Bednarz","year":"2000","unstructured":"Bednarz J, Teifel M, Friedl P, Engelmann K (2000) Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells. Acta Ophthalmol Scand 78(2):130\u2013136","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"2257_CR38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62(2):155\u2013169","journal-title":"Exp Eye Res"},{"issue":"3","key":"2257_CR39","first-page":"864","volume":"43","author":"GA Limb","year":"2002","unstructured":"Limb GA, Salt TE, Munro PMG, Moss SE, Khaw PT (2002) In vitro characterization of a spontaneously immortalized human M\u00fcller cell line (MIO-M1). Invest Ophthalmol Vis Sci 43(3):864\u2013869","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2257_CR40","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1167\/iovs.02-1172","volume":"44","author":"KH Eibl","year":"2003","unstructured":"Eibl KH, Banas B, Schoenfeld CL, May CA, Neubauer AS, Priglinger S, Kampik A, Welge-Lussen U (2003) Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 44:3556\u20133561","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1\u20132","key":"2257_CR41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363","journal-title":"J Immunol Methods"},{"issue":"12","key":"2257_CR42","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00417-007-0568-7","volume":"245","author":"MS Spitzer","year":"2007","unstructured":"Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurmann P (2007) Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells. Graefes Arch Clin Exp Ophthalmol 245(12):1837\u20131842","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"2257_CR43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/pr.55.4.4","volume":"55","author":"RR Neubig","year":"2003","unstructured":"Neubig RR (2003) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev 55(4):597\u2013606","journal-title":"Pharmacol Rev"},{"issue":"1 Suppl","key":"2257_CR44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2144\/000112517","volume":"43","author":"TJ Collins","year":"2007","unstructured":"Collins TJ (2007) ImageJ for microscopy. Biotechniques 43(1 Suppl):25\u201330","journal-title":"Biotechniques"},{"key":"2257_CR45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1084\/jem.115.3.453","volume":"115","author":"S Boyden","year":"1962","unstructured":"Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115:453\u2013466","journal-title":"J Exp Med"},{"issue":"12","key":"2257_CR46","first-page":"3407","volume":"33","author":"A Mazure","year":"1992","unstructured":"Mazure A, Grierson I (1992) In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 33(12):3407\u20133416","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2257_CR47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jso.2930410107","volume":"41","author":"Y Shimoyama","year":"1989","unstructured":"Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O (1989) Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay. J Surg Oncol 41(1):12\u201318","journal-title":"J Surg Oncol"},{"issue":"5","key":"2257_CR48","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jcrs.2008.11.064","volume":"35","author":"KH Eibl","year":"2009","unstructured":"Eibl KH, Liegl R, Kernt M, Priglinger S, Kampik A (2009) Alkylphosphocholines as a potential pharmacologic prophylaxis for posterior capsule opacification. J Cataract Refract Surg 35(5):900\u2013905","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"2257_CR49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2005.06.038","volume":"186","author":"A Dreux","year":"2006","unstructured":"Dreux A, Lamb D, Modjtahedi H, Fe G (2006) The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis 186(1):38\u201353","journal-title":"Atherosclerosis"},{"issue":"8","key":"2257_CR50","first-page":"1387","volume":"39","author":"TP Fleming","year":"1998","unstructured":"Fleming TP, Song Z, Andley UP (1998) Expression of growth control and differentiation genes in human lens epithelial cells with extended life span. Invest Ophthalmol Vis Sci 39(8):1387\u20131398","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2257_CR51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1010640118852","volume":"23","author":"T Shigemitsu","year":"1999","unstructured":"Shigemitsu T, Ishiguro K, Shimizu Y, Horiguchi M, Kasahara M, Arakaki S (1999) Immunocytochemical features of lens after cataract tissue-signalling molecules (growth factors, cytokines, other signalling molecules), cytoskeleton proteins, cellular and extracellular matrix proteins. Int Ophthalmol 23(3):137\u2013144","journal-title":"Int Ophthalmol"},{"issue":"11","key":"2257_CR52","first-page":"2304","volume":"36","author":"N Ibaraki","year":"1995","unstructured":"Ibaraki N, Lin LR, Reddy VN (1995) Effects of growth factors on proliferation and differentiation in human lens epithelial cells in early subculture. Invest Ophthalmol Vis Sci 36(11):2304\u20132312","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"2257_CR53","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0886-3350(96)80174-X","volume":"22","author":"O Nishi","year":"1996","unstructured":"Nishi O, Nishi K, Ohmoto Y (1996) Synthesis of interleukin-1, interleukin-6, and basic fibroblast growth factor by human cataract lens epithelial cells. J Cataract Refract Surg 22(Suppl 1):852\u2013858","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"2257_CR54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/08977190802610916","volume":"27","author":"L Iyengar","year":"2009","unstructured":"Iyengar L, Patkunanathan B, McAvoy JW, Lovicu FJ (2009) Growth factors involved in aqueous humour-induced lens cell proliferation. Growth Factors 27(1):50\u201362","journal-title":"Growth Factors"},{"issue":"4","key":"2257_CR55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000267024","volume":"22","author":"JM Ru\u00edz","year":"1990","unstructured":"Ru\u00edz JM, Medrano M, Ali\u00f3 JL (1990) Inhibition of posterior capsule opacification by 5-fluorouracil in rabbits. Ophthalmic Res 22(4):201\u2013208","journal-title":"Ophthalmic Res"},{"issue":"3","key":"2257_CR56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0886-3350(13)80579-2","volume":"20","author":"WJ Power","year":"1994","unstructured":"Power WJ, Neylan D, Collum LM (1994) Daunomycin as an inhibitor of human lens epithelial cell proliferation in culture. J Cataract Refract Surg 20(3):287\u2013290","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"2257_CR57","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1442-9071.2009.01921.x","volume":"36","author":"TD Walker","year":"2008","unstructured":"Walker TD (2008) Pharmacological attempts to reduce posterior capsule opacification after cataract surgery\u2014a review. Clin Exp Ophthalmol 36(9):883\u2013890","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"2257_CR58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/112067210801800311","volume":"18","author":"S Kang","year":"2008","unstructured":"Kang S, Kim M, Park S, Joo C (2008) Comparison of clinical results between heparin surface modified hydrophilic acrylic and hydrophobic acrylic intraocular lens. Eur J Ophthalmol 18(3):377\u2013383","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"2257_CR59","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bjo.2006.106468","volume":"91","author":"TM Rabsilber","year":"2007","unstructured":"Rabsilber TM, Limberger I, Reuland AJ, Holzer MP, Auffarth GU (2007) Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial. Br J Ophthalmol 91(7):912\u2013915","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2257_CR60","first-page":"739","volume":"291","author":"VA Pollack","year":"1999","unstructured":"Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD, Barbacci EG, Pustilnik LR, Smolarek TA, Davis JA, Vaidya MP, Arnold LD, Doty JL, Iwata KK, Morin MJ (1999) Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice. J Pharmacol Exp Ther 291(2):739\u2013748","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"2257_CR61","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/ICO.0b013e31818fdbc6","volume":"28","author":"KS Johnson","year":"2009","unstructured":"Johnson KS, Levin F, Chu DS (2009) Persistent corneal epithelial defect associated with erlotinib treatment. Cornea 28(6):706\u2013707","journal-title":"Cornea"},{"key":"2257_CR62","unstructured":"US Food and Drug Administration (2010). Tarceva (erlotinib): full prescribing information. Available: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021743s14s16lbl.pdf . Accessed 19 January 2012"},{"key":"2257_CR63","unstructured":"US Food and Drug Administration (2009) Tarceva (erlotinib) May 2009\u2014safety information. Available: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm150596.htm . Accessed 28 January 2012"},{"issue":"5","key":"2257_CR64","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1167\/iovs.03-1187","volume":"45","author":"JM Maidment","year":"2004","unstructured":"Maidment JM, Duncan G, Tamiya S, Collison DJ, Wang L, Wormstone IM (2004) Regional differences in tyrosine kinase receptor signaling components determine differential growth patterns in the human lens. Invest Ophthalmol Vis Sci 45(5):1427\u20131435","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2257_CR65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0047-6374(99)00111-6","volume":"113","author":"DK Bhuyan","year":"2000","unstructured":"Bhuyan DK, Reddy PG, Bhuyan KC (2000) Growth factor receptor gene and protein expressions in the human lens. Mech Ageing Dev 113(3):205\u2013218","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"2257_CR66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00424-008-0514-5","volume":"457","author":"A Meissner","year":"2008","unstructured":"Meissner A, Noack T (2008) Proliferation of human lens epithelial cells (HLE-B3) is inhibited by blocking of voltage-gated calcium channels. Pflugers Arch 457(1):47\u201359","journal-title":"Pflugers Arch"},{"issue":"6","key":"2257_CR67","first-page":"1509","volume":"5","author":"Q Jiang","year":"2012","unstructured":"Jiang Q (2012) Dexamethasone inhibits TGF-\u03b22-induced migration of human lens epithelial cells: implications for posterior capsule opacification prevention. Mol Med Rep 5(6):1509\u20131513","journal-title":"Mol Med Rep"},{"issue":"3","key":"2257_CR68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.exer.2011.01.009","volume":"92","author":"J Li","year":"2011","unstructured":"Li J, Tang X, Chen X (2011) Comparative effects of TGF-\u03b22\/Smad2 and TGF-\u03b22\/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line. Exp Eye Res 92(3):173\u2013179","journal-title":"Exp Eye Res"},{"issue":"7","key":"2257_CR69","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00417-004-0886-y","volume":"242","author":"B Nebe","year":"2004","unstructured":"Nebe B, Kunz F, Peters A, Rychly J, Noack T, Beck R (2004) Induction of apoptosis by the calcium antagonist mibefradil correlates with depolarization of the membrane potential and decreased integrin expression in human lens epithelial cells. Graefes Arch Clin Exp Ophthalmol 242(7):597\u2013604","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"2257_CR70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00417-004-1095-4","volume":"243","author":"J Sun","year":"2005","unstructured":"Sun J, Xie L, Wang Y, Liu T (2005) Inhibition of human lens epithelial B-3 cell proliferation by adenovirus-mediated transfer of antisense c-myc construct. Graefes Arch Clin Exp Ophthalmol 243(6):601\u2013606","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"2257_CR71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.etap.2005.07.012","volume":"21","author":"IM Wormstone","year":"2006","unstructured":"Wormstone IM, Collison DJ, Hansom SP, Duncan G (2006) A focus on the human lens in vitro. Environ Toxicol Pharmacol 21(2):215\u2013221","journal-title":"Environ Toxicol Pharmacol"},{"issue":"2","key":"2257_CR72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbrc.2012.05.134","volume":"423","author":"MM Saller","year":"2012","unstructured":"Saller MM, Prall WC, Docheva D, Schonitzer V, Popov T, Anz D, Clausen-Schaumann H, Mutschler W, Volkmer E, Schieker M, Polzer H (2012) Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression. Biochem Biophys Res Commun 423(2):379\u2013385","journal-title":"Biochem Biophys Res Commun"},{"issue":"5A","key":"2257_CR73","first-page":"3639","volume":"23","author":"S Yano","year":"2003","unstructured":"Yano S, Kondo K, Yamaguchi M, Richmond G, Hutchison M, Wakeling A, Averbuch S, Wadsworth P (2003) Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition. Anticancer Res 23(5A):3639\u20133650","journal-title":"Anticancer Res"},{"key":"2257_CR74","first-page":"2559","volume":"16","author":"C Liang","year":"2010","unstructured":"Liang C, Tai M, Chang Y, Chen Y, Chen C, Chien MW, Chen JT (2010) Glucosamine inhibits epidermal growth factor-induced proliferation and cell-cycle progression in retinal pigment epithelial cells. Mol Vis 16:2559\u20132571","journal-title":"Mol Vis"},{"issue":"4","key":"2257_CR75","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000101926","volume":"221","author":"F Yan","year":"2007","unstructured":"Yan F, Hui Y, Li Y, Guo C, Meng H (2007) Epidermal growth factor receptor in cultured human retinal pigment epithelial cells. Ophthalmologica 221(4):244\u2013250","journal-title":"Ophthalmologica"},{"issue":"6","key":"2257_CR76","first-page":"2112","volume":"34","author":"SE Wilson","year":"1993","unstructured":"Wilson SE, Lloyd SA, He YG, McCash CS (1993) Extended life of human corneal endothelial cells transfected with the SV40 large T antigen. Invest Ophthalmol Vis Sci 34(6):2112\u20132123","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2257-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2257-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2257-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T07:26:40Z","timestamp":1562570800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2257-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,18]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2257-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,18]]}}}